Dietary formula may shield menopausal Women's brains from Obesity-Linked decline
NCT ID NCT07501377
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily powder containing fiber and plant compounds (inulin, resveratrol, quercetin) can reduce brain inflammation in 120 overweight women aged 35-60 who are going through menopause. Participants take the supplement or a placebo for 6 months, and researchers use brain scans and blood/stool tests to measure changes. The goal is to see if improving gut health can protect the brain from inflammation and lower the risk of memory problems later in life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND/OR OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Max Planck Institute for Human Cognitive and Brain Sciences
RECRUITINGLeipzig, Saxony, 04103, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may soothe menopause symptoms — a trial puts it to the test
- Can yoga and breathing curb emotional eating? a new trial investigates
- A fiber supplement may help perimenopausal women — a trial puts it to the test
- Menopause heart risk targeted by tailored exercise and diet programs
- No-Needle weight loss patch enters human testing
- New supplement aims to ease menopause-related body changes in midlife women